UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 137

Sortiert nach

Mutations in NALP12 cause hereditary periodic fever syndromes

Proceedings of the National Academy of Sciences - PNAS, 2008-02, Vol.105 (5), p.1614-1619

2008

Link zum Volltext

Verfügbarkeit prüfen

Immune checkpoint inhibitors in MITF family translocation renal cell carcinomas and genetic correlates of exceptional responders

Journal for immunotherapy of cancer, 2018-12, Vol.6 (1), p.159-159, Article 159

2018

Link zum Volltext

Verfügbarkeit prüfen

I feel pain here

Archives de pédiatrie : organe officiel de la Société française de pédiatrie, 2019-07, Vol.26 (5), p.252-253

Landman-Parker, J.

2019

Link zum Volltext

Verfügbarkeit prüfen

Lymphome de Hodgkin : données physiopathologiques récentes

Archives de pédiatrie (Paris), 2009-06, Vol.16 (6), p.667-668

2009

Link zum Volltext

Verfügbarkeit prüfen

New insights in Hodgkin's lymphoma biology

Archives de pédiatrie : organe officiel de la Société française de pédiatrie, 2009-06, Vol.16 (6), p.667-668

2009

Link zum Volltext

Verfügbarkeit prüfen

Abatacept is useful in autoimmune cytopenia with immunopathologic manifestations caused by CTLA-4 defects

Blood, 2022-01, Vol.139 (2), p.300-304

2022

Link zum Volltext

Verfügbarkeit prüfen

Lymphocyte-Predominant Hodgkin’s Lymphoma in Children: Therapeutic Abstention After Initial Lymph Node Resection—A Study of the French Society of Pediatric Oncology

Journal of clinical oncology, 2003-08, Vol.21 (15), p.2948-2952

2003

Link zum Volltext

Verfügbarkeit prüfen

[18F]FDG in childhood lymphoma: clinical utility and impact on management

European journal of nuclear medicine and molecular imaging, 2002-09, Vol.29 (9), p.1155-1165

2002

Link zum Volltext

Verfügbarkeit prüfen

Les thrombopénies génétiques

Archives de pédiatrie : organe officiel de la Société française de pédiatrie, 2010-08, Vol.17 (8), p.1185-1191

2010

Link zum Volltext

Verfügbarkeit prüfen

Existe-t-il un risque de déficit corticotrope au décours du traitement d’induction d’une leucémie aiguë lymphoblastique ?

Archives de pédiatrie : organe officiel de la Société française de pédiatrie, 2010-12, Vol.17 (12), p.1637-1644

2010

Link zum Volltext

Verfügbarkeit prüfen

Maladie de Hodgkin et auto-immunité chez l’enfant : à propos de 11 observations

Archives de pédiatrie : organe officiel de la Société française de pédiatrie, 2011-04, Vol.18 (4), p.376-382

2011

Link zum Volltext

Verfügbarkeit prüfen

Age and high-dose methotrexate are associated to clinical acute encephalopathy in FRALLE 93 trial for acute lymphoblastic leukemia in children

Leukemia, 2007-02, Vol.21 (2), p.238-247

2007

Link zum Volltext

Verfügbarkeit prüfen

Localized Childhood Hodgkin’s Disease: Response-Adapted Chemotherapy With Etoposide, Bleomycin, Vinblastine, and Prednisone Before Low-Dose Radiation Therapy—Results of the French Society of Pediatric Oncology Study MDH90

Journal of clinical oncology, 2000-04, Vol.18 (7), p.1500-1507

2000

Link zum Volltext

Verfügbarkeit prüfen

SPRED1, a RAS MAPK pathway inhibitor that causes Legius syndrome, is a tumour suppressor downregulated in paediatric acute myeloblastic leukaemia

Oncogene, 2015-01, Vol.34 (5), p.631-638

2015

Link zum Volltext

Verfügbarkeit prüfen

SPRED1 germline mutations caused a neurofibromatosis type 1 overlapping phenotype

Journal of medical genetics, 2009-07, Vol.46 (7), p.425-430

2009

Link zum Volltext

Verfügbarkeit prüfen

Expression of CD34 and CD7 on human T-cell acute lymphoblastic leukemia discriminates functionally heterogeneous cell populations

Leukemia, 2011-08, Vol.25 (8), p.1249-1258

2011

Link zum Volltext

Verfügbarkeit prüfen

GENETIC PREDISPOSITION OF FAMILIAL HODGKIN LYMPHOMA

Hematological oncology, 2019-06, Vol.37 (S2), p.364-365

2019

Link zum Volltext

Verfügbarkeit prüfen

Rapid childhood T-ALL growth in xenograft models correlates with mature phenotype and NF-κB pathway activation but not with poor prognosis

Leukemia, 2015-04, Vol.29 (4), p.977-980

2015

Link zum Volltext

Verfügbarkeit prüfen

Multi-centre pilot study of 2-chlorodeoxyadenosine and cytosine arabinoside combined chemotherapy in refractory Langerhans cell histiocytosis with haematological dysfunction

European journal of cancer (1990), 2005-11, Vol.41 (17), p.2682-2689

2005

Link zum Volltext

Verfügbarkeit prüfen

S204: PEMBROLIZUMAB IN CHILDREN AND YOUNG ADULTS WITH NEWLY DIAGNOSED CLASSICAL HODGKIN LYMPHOMA WITH SLOW EARLY RESPONSE TO FRONTLINE CHEMOTHERAPY: THE PHASE 2, OPEN‐LABEL, KEYNOTE‐667 STUDY

HemaSphere, 2022-06, Vol.6, p.105-106

2022

Link zum Volltext

Verfügbarkeit prüfen

Treatment of childhood acute myeloblastic leukemia: dose intensification improves outcome and maintenance therapy is of no benefit - multicenter studies of the French LAME (Leucémie Aiguë Myéloblastique Enfant) Cooperative Group

Leukemia, 2005-12, Vol.19 (12), p.2082-2089

2005

Link zum Volltext

Verfügbarkeit prüfen

Fusariose disséminée chez deux enfants neutropéniques

Archives de pédiatrie : organe officiel de la Société française de pédiatrie, 2005-07, Vol.12 (7), p.1116-1119

2005

Link zum Volltext

Verfügbarkeit prüfen

Vécu des adolescents guéris d'une leucémie aiguë lymphoblastique

Archives de pédiatrie : organe officiel de la Société française de pédiatrie, 2005-11, Vol.12 (11), p.1591-1599

2005

Link zum Volltext

Verfügbarkeit prüfen

A PHASE 1/2 STUDY OF BRENTUXIMAB VEDOTIN IN PEDIATRIC PATIENTS WITH RELAPSED/REFRACTORY (R/R) SYSTEMIC ANAPLASTIC LARGE‐CELL LYMPHOMA (SALCL) OR R/R HODGKIN LYMPHOMA (HL)

Hematological oncology, 2017-06, Vol.35 (S2), p.248-249

2017

Link zum Volltext

Verfügbarkeit prüfen

Use of Recombinant Human Granulocyte Colony-Stimulating Factor to Increase Chemotherapy Dose-Intensity: A Randomized Trial in Very High-Risk Childhood Acute Lymphoblastic Leukemia

Journal of clinical oncology, 2000-04, Vol.18 (7), p.1517-1524

2000

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 137

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(124)
Mit Volltextzugriff
(123)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(72)
Science & Technology
(61)
Life Sciences & Biomedicine
(60)
Child
(54)
Male
(46)
Female
(41)
Child, Preschool
(37)
Biological And Medical Sciences
(34)
Adolescent
(33)
Medical Sciences
(33)
Hematology
(30)
Oncology
(30)
Infant
(23)
Hematologic And Hematopoietic Diseases
(16)
Sciences Biologiques Et Medicales
(15)
Sciences Medicales
(15)
Pediatrics
(14)
Prognosis
(14)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(13)
Adult
(12)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Mutations in NALP12 cause hereditary periodic fever syndromes

Immune checkpoint inhibitors in MITF family translocation renal cell carcinomas and genetic correlates of exceptional responders

I feel pain here

Lymphome de Hodgkin : données physiopathologiques récentes

New insights in Hodgkin's lymphoma biology

Abatacept is useful in autoimmune cytopenia with immunopathologic manifestations caused by CTLA-4 defects

Lymphocyte-Predominant Hodgkin’s Lymphoma in Children: Therapeutic Abstention After Initial Lymph Node Resection—A Study of the French Society of Pediatric Oncology

[18F]FDG in childhood lymphoma: clinical utility and impact on management

Les thrombopénies génétiques

Existe-t-il un risque de déficit corticotrope au décours du traitement d’induction d’une leucémie aiguë lymphoblastique ?

Maladie de Hodgkin et auto-immunité chez l’enfant : à propos de 11 observations

Age and high-dose methotrexate are associated to clinical acute encephalopathy in FRALLE 93 trial for acute lymphoblastic leukemia in children

Localized Childhood Hodgkin’s Disease: Response-Adapted Chemotherapy With Etoposide, Bleomycin, Vinblastine, and Prednisone Before Low-Dose Radiation Therapy—Results of the French Society of Pediatric Oncology Study MDH90

SPRED1, a RAS MAPK pathway inhibitor that causes Legius syndrome, is a tumour suppressor downregulated in paediatric acute myeloblastic leukaemia

SPRED1 germline mutations caused a neurofibromatosis type 1 overlapping phenotype

Expression of CD34 and CD7 on human T-cell acute lymphoblastic leukemia discriminates functionally heterogeneous cell populations

GENETIC PREDISPOSITION OF FAMILIAL HODGKIN LYMPHOMA

Rapid childhood T-ALL growth in xenograft models correlates with mature phenotype and NF-κB pathway activation but not with poor prognosis

Multi-centre pilot study of 2-chlorodeoxyadenosine and cytosine arabinoside combined chemotherapy in refractory Langerhans cell histiocytosis with haematological dysfunction

S204: PEMBROLIZUMAB IN CHILDREN AND YOUNG ADULTS WITH NEWLY DIAGNOSED CLASSICAL HODGKIN LYMPHOMA WITH SLOW EARLY RESPONSE TO FRONTLINE CHEMOTHERAPY: THE PHASE 2, OPEN‐LABEL, KEYNOTE‐667 STUDY

Treatment of childhood acute myeloblastic leukemia: dose intensification improves outcome and maintenance therapy is of no benefit - multicenter studies of the French LAME (Leucémie Aiguë Myéloblastique Enfant) Cooperative Group

Fusariose disséminée chez deux enfants neutropéniques

Vécu des adolescents guéris d'une leucémie aiguë lymphoblastique

A PHASE 1/2 STUDY OF BRENTUXIMAB VEDOTIN IN PEDIATRIC PATIENTS WITH RELAPSED/REFRACTORY (R/R) SYSTEMIC ANAPLASTIC LARGE‐CELL LYMPHOMA (SALCL) OR R/R HODGKIN LYMPHOMA (HL)

Use of Recombinant Human Granulocyte Colony-Stimulating Factor to Increase Chemotherapy Dose-Intensity: A Randomized Trial in Very High-Risk Childhood Acute Lymphoblastic Leukemia

Suchergebnisse filtern